Good Distribution Practice (GDP)
Good Distribution Practice is a set of requirements and procedures for companies involved in the entire logistics chain of medicinal products. The principles of Good Distribution Practice were developed on the basis of the European Commission's guidelines and the European Parliament's Directive (2011/62/EU of June 8, 2011) - Good Distribution Practice (GDP). The requirements set out in the aforementioned documents apply to national and international companies.
What are medicinal products?
- Medical products
- Vaccines
- Medicines
- Food supplements and foodstuffs for special nutritional purposes
- Psychoactive substances
- Cosmetics
- Herbs
- Medical devices
It is made up of companies that are involved in the following processes:
- Transportation of medicinal products
- Storage of the above-mentioned carriers and pick and pack companies
Legal basis:
The Medicinal Products Act, which was amended on February 8, 2015, introduces a number of new obligations for entrepreneurs involved in the wholesale or brokerage of medicinal products. Detailed guidelines can be found in the Regulation of the Minister of Health of March 13, 2015 on the requirements for good distribution practice (Journal of Laws of March 10, 2017, item 509). It aims in particular to prevent falsified medicinal products from entering the legal supply chain, as required by Directive 2011/62/EU of June 8, 2011.